Pharmacist's role in HIV care in France. Implication for clinical improvement of people living with HIV worldwide.
Adult
Anti-HIV Agents
/ pharmacology
Community Pharmacy Services
Comorbidity
Female
France
HIV Infections
/ drug therapy
Health Knowledge, Attitudes, Practice
Humans
Male
Middle Aged
Patient Satisfaction
/ statistics & numerical data
Pharmaceutical Services, Online
Pharmacists
Pharmacy Service, Hospital
Practice Patterns, Pharmacists'
/ statistics & numerical data
Professional Role
Surveys and Questionnaires
Viral Load
/ drug effects
HIV/AIDS
antiretrovirals
clinical pharmacy
health policy
patient safety
Journal
Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
23
06
2020
revised:
28
06
2020
accepted:
29
06
2020
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
30
6
2021
Statut:
ppublish
Résumé
In France, antiretroviral (ARV) treatment can be dispensed by hospital and/or community pharmacies. Since January 2016, an online patient medication file can be used to optimize dispensing, but medication interviews have not yet been incorporated into this system. To understand both people living with HIV (PLHIV) and their pharmacists' habits and expectations of patient medication file and interviews, two consecutive national surveys were organized. The first one, carried out in October 2016 in care centers, was an anonymous questionnaire for PLHIV. The second one was an online survey for community and hospital pharmacies conducted in February 2017. A total of 1137 PLHIV (68% men, of mean age 50.2 ± 11.5 years, CD4 count 671 ± 354, 90% with undetectable HIV viral load (VL) and 64.2% reporting comorbidities) and 246 pharmacies responded. While the existence of the online medication file is known by 58% of PLHIV, only 40% of pharmacists declare it to be systematically offered. It was offered to 120/694 (17%) PLHIV and 96 (80%) accepted it. Currently, 78 (7%) PLHIV feel well taken care of because they are offered medication interviews, 343/1078 (32%) would like to take advantage of this program, mainly those with a shorter ARV duration (OR ARV duration 0.97 [0.95-0.99]), a VL less often undetectable (OR undetectable VL 0.55 [0.31-0.98]), and those who feel anxious more often (OR anxious 2.38 [1.48-3.84]). These results suggest that better implementation of medication files and interviews will strengthen current clinical pathways.
Identifiants
pubmed: 32909403
doi: 10.1002/prp2.629
pmc: PMC7507099
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00629Informations de copyright
© 2020 The Authors. Pharmacology Research & Perspectives published by British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics and John Wiley & Sons Ltd.
Références
J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e67-73
pubmed: 23023860
J Manag Care Spec Pharm. 2014 Aug;20(8):844-50
pubmed: 25062078
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
AIDS Care. 2017 Jan;29(1):105-111
pubmed: 27334840
J Manag Care Spec Pharm. 2020 Feb;26(2):95-102
pubmed: 32011966
AIDS Rev. 2019;21(4):195-210
pubmed: 31834321
Clin Interv Aging. 2016 Aug 26;11:1149-57
pubmed: 27616883
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
Can J Hosp Pharm. 2012 Mar;65(2):125-45
pubmed: 22529405
J Gen Intern Med. 2013 Oct;28(10):1302-10
pubmed: 23605401
Clin Infect Dis. 2015 Feb 1;60(3):463-72
pubmed: 25344539
Antivir Ther. 2010;15(3):413-23
pubmed: 20516560
Am J Health Syst Pharm. 2015 May 1;72(9):753-6
pubmed: 25873623
Am J Health Syst Pharm. 2016 Jun 1;73(11):757-63
pubmed: 27126831
Pharmacol Res Perspect. 2020 Oct;8(5):e00629
pubmed: 32909403